Skip to main content
PMC home page
Gut logoLink to Gut
. 2002 Oct;51(Suppl 5):v10–v12. doi: 10.1136/gut.51.suppl_5.v10

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease

J Eaden, J Mayberry
PMCID: PMC1867735  PMID: 12221032

Full Text

The Full Text of this article is available as a PDF (85.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axon A. T., Lynch D. A. Surveillance for ulcerative colitis does not and cannot work. Gastroenterology. 1994 Apr;106(4):1129–1131. doi: 10.1016/0016-5085(94)90785-4. [DOI] [PubMed] [Google Scholar]
  2. Bernstein C. N., Shanahan F., Weinstein W. M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994 Jan 8;343(8889):71–74. doi: 10.1016/s0140-6736(94)90813-3. [DOI] [PubMed] [Google Scholar]
  3. Blackstone M. O., Riddell R. H., Rogers B. H., Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981 Feb;80(2):366–374. [PubMed] [Google Scholar]
  4. Brentnall T. A., Haggitt R. C., Rabinovitch P. S., Kimmey M. B., Bronner M. P., Levine D. S., Kowdley K. V., Stevens A. C., Crispin D. A., Emond M. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996 Feb;110(2):331–338. doi: 10.1053/gast.1996.v110.pm8566577. [DOI] [PubMed] [Google Scholar]
  5. Broomé U., Lindberg G., Löfberg R. Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology. 1992 Jun;102(6):1877–1880. doi: 10.1016/0016-5085(92)90308-l. [DOI] [PubMed] [Google Scholar]
  6. Broomé U., Löfberg R., Veress B., Eriksson L. S. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995 Nov;22(5):1404–1408. doi: 10.1002/hep.1840220511. [DOI] [PubMed] [Google Scholar]
  7. Broström O., Löfberg R., Ost A., Reichard H. Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut. 1986 Dec;27(12):1408–1413. doi: 10.1136/gut.27.12.1408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Choi P. M., Nugent F. W., Schoetz D. J., Jr, Silverman M. L., Haggitt R. C. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993 Aug;105(2):418–424. doi: 10.1016/0016-5085(93)90715-o. [DOI] [PubMed] [Google Scholar]
  9. Choi P. M. Predominance of rectosigmoid neoplasia in ulcerative colitis and its implication on cancer surveillance. Gastroenterology. 1993 Feb;104(2):666–667. doi: 10.1016/0016-5085(93)90455-l. [DOI] [PubMed] [Google Scholar]
  10. Connell W. R., Lennard-Jones J. E., Williams C. B., Talbot I. C., Price A. B., Wilkinson K. H. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994 Oct;107(4):934–944. doi: 10.1016/0016-5085(94)90216-x. [DOI] [PubMed] [Google Scholar]
  11. Connell W. R., Talbot I. C., Harpaz N., Britto N., Wilkinson K. H., Kamm M. A., Lennard-Jones J. E. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994 Oct;35(10):1419–1423. doi: 10.1136/gut.35.10.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Devroede G. J., Taylor W. F., Sauer W. G., Jackman R. J., Stickler G. B. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med. 1971 Jul 1;285(1):17–21. doi: 10.1056/NEJM197107012850103. [DOI] [PubMed] [Google Scholar]
  13. EDWARDS F. C., TRUELOVE S. C. THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. Gut. 1964 Feb;5:1–22. doi: 10.1136/gut.5.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Eaden J. A., Abrams K. R., Mayberry J. F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001 Apr;48(4):526–535. doi: 10.1136/gut.48.4.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Eaden J., Abrams K., Ekbom A., Jackson E., Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000 Feb;14(2):145–153. doi: 10.1046/j.1365-2036.2000.00698.x. [DOI] [PubMed] [Google Scholar]
  16. Ekbom A., Helmick C., Zack M., Adami H. O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990 Aug 11;336(8711):357–359. doi: 10.1016/0140-6736(90)91889-i. [DOI] [PubMed] [Google Scholar]
  17. Ekbom A., Helmick C., Zack M., Adami H. O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990 Nov 1;323(18):1228–1233. doi: 10.1056/NEJM199011013231802. [DOI] [PubMed] [Google Scholar]
  18. Engelsgjerd M., Farraye F. A., Odze R. D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999 Dec;117(6):1288–1491. doi: 10.1016/s0016-5085(99)70278-7. [DOI] [PubMed] [Google Scholar]
  19. Gyde S. N., Prior P., Allan R. N., Stevens A., Jewell D. P., Truelove S. C., Lofberg R., Brostrom O., Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988 Feb;29(2):206–217. doi: 10.1136/gut.29.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut. 1990 Oct;31(10):1089–1092. doi: 10.1136/gut.31.10.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jayanthi V., Probert C. S., Pinder D., Wicks A. C., Mayberry J. F. Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med. 1992 Feb;82(298):125–138. [PubMed] [Google Scholar]
  22. Jones H. W., Grogono J., Hoare A. M. Surveillance in ulcerative colitis: burdens and benefit. Gut. 1988 Mar;29(3):325–331. doi: 10.1136/gut.29.3.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Karlén P., Kornfeld D., Broström O., Löfberg R., Persson P. G., Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998 May;42(5):711–714. doi: 10.1136/gut.42.5.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Koobatian G. J., Choi P. M. Safety of surveillance colonoscopy in long-standing ulcerative colitis. Am J Gastroenterol. 1994 Sep;89(9):1472–1475. [PubMed] [Google Scholar]
  25. Kornfeld D., Ekbom A., Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut. 1997 Oct;41(4):522–525. doi: 10.1136/gut.41.4.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lashner B. A., Hanauer S. B., Silverstein M. D. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med. 1988 Feb;108(2):274–278. doi: 10.7326/0003-4819-108-2-274. [DOI] [PubMed] [Google Scholar]
  27. Lennard-Jones J. E., Melville D. M., Morson B. C., Ritchie J. K., Williams C. B. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990 Jul;31(7):800–806. doi: 10.1136/gut.31.7.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Loftus E. V., Jr, Aguilar H. I., Sandborn W. J., Tremaine W. J., Krom R. A., Zinsmeister A. R., Graziadei I. W., Wiesner R. H. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology. 1998 Mar;27(3):685–690. doi: 10.1002/hep.510270308. [DOI] [PubMed] [Google Scholar]
  29. Lynch D. A., Lobo A. J., Sobala G. M., Dixon M. F., Axon A. T. Failure of colonoscopic surveillance in ulcerative colitis. Gut. 1993 Aug;34(8):1075–1080. doi: 10.1136/gut.34.8.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Moody G. A., Jayanthi V., Probert C. S., Mac Kay H., Mayberry J. F. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1179–1183. doi: 10.1097/00042737-199612000-00009. [DOI] [PubMed] [Google Scholar]
  31. Pinczowski D., Ekbom A., Baron J., Yuen J., Adami H. O. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994 Jul;107(1):117–120. doi: 10.1016/0016-5085(94)90068-x. [DOI] [PubMed] [Google Scholar]
  32. Probert C. S., Jayanthi V., Pinder D., Wicks A. C., Mayberry J. F. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992 May;33(5):687–693. doi: 10.1136/gut.33.5.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Provenzale D., Kowdley K. V., Arora S., Wong J. B. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology. 1995 Oct;109(4):1188–1196. doi: 10.1016/0016-5085(95)90578-2. [DOI] [PubMed] [Google Scholar]
  34. Ransohoff D. F. Colon cancer in ulcerative colitis. Gastroenterology. 1988 Apr;94(4):1089–1091. doi: 10.1016/0016-5085(88)90573-2. [DOI] [PubMed] [Google Scholar]
  35. Reiser J. R., Waye J. D., Janowitz H. D., Harpaz N. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol. 1994 Jan;89(1):119–122. [PubMed] [Google Scholar]
  36. Riddell R. H., Goldman H., Ransohoff D. F., Appelman H. D., Fenoglio C. M., Haggitt R. C., Ahren C., Correa P., Hamilton S. R., Morson B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983 Nov;14(11):931–968. doi: 10.1016/s0046-8177(83)80175-0. [DOI] [PubMed] [Google Scholar]
  37. Riddell R. H. Screening strategies in gastrointestinal cancer. Scand J Gastroenterol Suppl. 1990;175:177–184. doi: 10.3109/00365529009093141. [DOI] [PubMed] [Google Scholar]
  38. Rubin P. H., Friedman S., Harpaz N., Goldstein E., Weiser J., Schiller J., Waye J. D., Present D. H. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999 Dec;117(6):1295–1300. doi: 10.1016/s0016-5085(99)70279-9. [DOI] [PubMed] [Google Scholar]
  39. Sachar D. B. Cancer in Crohn's disease: dispelling the myths. Gut. 1994 Nov;35(11):1507–1508. doi: 10.1136/gut.35.11.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sahai A. V., Mishra G., Penman I. D., Williams D., Wallace M. B., Hadzijahic N., Pearson A., Vanvelse A., Hoffman B. J., Hawes R. H. EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest Endosc. 2000 Aug;52(2):153–159. doi: 10.1067/mge.2000.107910. [DOI] [PubMed] [Google Scholar]
  41. Stowe S. P., Redmond S. R., Stormont J. M., Shah A. N., Chessin L. N., Segal H. L., Chey W. Y. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990 Jan;98(1):104–110. doi: 10.1016/0016-5085(90)91297-j. [DOI] [PubMed] [Google Scholar]
  42. Woolrich A. J., DaSilva M. D., Korelitz B. I. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology. 1992 Aug;103(2):431–438. doi: 10.1016/0016-5085(92)90831-i. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES